How Long on Wegovy to Lose Weight: A Comprehensive Guide to Your Weight Loss Journey

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by activating GLP-1 receptors in the brain and gut, signaling fullness and reducing hunger—but the timeline to visible weight loss depends on your starting dose, genetics, and how your body responds. Understanding what to expect in the first weeks and months helps set realistic goals and builds confidence in your weight loss journey.

Timeline: When Does Semaglutide Start Working?

Most patients report reduced appetite and food cravings within 3–7 days of their first injection or dose, even before significant weight loss occurs. This early appetite suppression is one of semaglutide's defining features and often motivates people to stick with treatment. The medication reaches steady-state levels in your bloodstream after about 4–5 weeks, meaning your body fully adjusts to the compound and you experience its maximum effect.

Measurable weight loss typically appears by week 2–4, though the amount varies widely. A landmark clinical trial showed that patients lost an average of 5–7 pounds in the first month, with loss accelerating in months 2–4 as tolerance builds. By month 3, many patients report dropping 10–15 pounds, and continued progress continues into months 4–6 when the dose may be increased to enhance results.

Month-by-Month Weight Loss Expectations

Month 1 focuses on adjustment: appetite decreases, nausea may occur briefly, and weight loss ranges from 2–8 pounds depending on your starting weight and adherence. Heavier individuals often see faster initial losses due to higher caloric deficit. Month 2–3 is the acceleration phase, where most patients lose 8–12 additional pounds as their body adapts and the medication's effects stabilize.

Months 4–6 mark the consistency phase, with steady losses of 1–2 pounds per week if dose increases continue and lifestyle remains stable. By month 6, total weight loss averages 15–25 pounds for most users, though some exceed 30+ pounds depending on baseline weight, genetics, and commitment. Individual variation is large: genetic factors like FTO rs9939609 variants sensitivity influence how quickly your body responds to treatment.

Factors That Speed Up or Slow Down Your Results

Genetics play a powerful role in semaglutide response. People with certain GIPR gene variants experience stronger appetite suppression and faster weight loss, while others see slower but steady progress. PlexusDx's Precision Peptide Genetic Test maps 14 weight-regulation pathways and identifies your genetic predispositions to GLP-1 sensitivity, allowing your provider to personalize your treatment plan from day one.

Lifestyle factors matter equally: consistent exercise, adequate protein intake (100+ grams daily), and sleep quality of 7–9 hours nightly amplify semaglutide's effects. Dehydration, skipped doses, and high-stress eating blunt results. Your starting weight also influences speed—patients above 300 pounds often lose 30+ pounds in 6 months, while those closer to their goal weight see 15–20 pounds. Consistency beats intensity: missing doses or staying on the same dose for months slows progress.

How PlexusDx Semaglutide Injection Optimizes Your Timeline

PlexusDx's compounded Semaglutide Injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan) is manufactured by licensed 503A compounding pharmacies, meets pharmaceutical-grade standards, and costs a fraction of brand-name Wegovy. Your dose may need to go up as your body adapts—your price won't. PlexusDx serves all 50 states without insurance requirements, and your medication is HSA/FSA eligible, removing barriers to consistent treatment.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Staying Consistent and Overcoming Plateaus

Plateaus typically occur at months 3 and 5–6 as your body adjusts to the current dose and appetite suppression peaks at that level. A dose increase (if medically appropriate) usually breaks the plateau within 2–3 weeks, revealing another 4–8 pounds of loss. Some patients stop losing weight because they've achieved their goal; others plateau because adherence slips or calorie intake creeps upward over time.

Consistency is non-negotiable: missing doses by even one week can reset your tolerance and delay results. Weight fluctuations of ±2–3 pounds day-to-day are normal and don't indicate failure. If you lose no weight over 4 consecutive weeks despite perfect adherence, consult your provider about dose adjustment, lifestyle tweaks, or whether genetic testing might reveal an MC4R or FTO predisposition requiring a dual-peptide approach like GLP-Squared (Semaglutide + Tirzepatide combination).

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight should I expect to lose in my first month on semaglutide?

Most patients lose 2–8 pounds in month 1, with appetite reduction appearing within days and measurable weight loss by week 2–4. Heavier individuals typically see faster initial loss. Individual results depend on starting weight, genetics, and whether you combine the medication with calorie awareness and exercise.

What does clinical evidence say about semaglutide weight loss over 6 months?

Landmark trials show average weight loss of 10–15% of body weight by 6 months—roughly 15–30 pounds for most users. Patients who consistently increase their dose and maintain lifestyle changes achieved up to 20% weight loss. PlexusDx patients with genetic insights often optimize results because their provider adjusts timing and strategies based on their peptide-pathway profile.

Can I start semaglutide at PlexusDx without insurance, and what does it cost?

PlexusDx's compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and works across all 50 states with no insurance required and no membership fees. Your dose may increase as you progress—your price remains flat. HSA/FSA funds cover the medication, and the Precision Peptide Genetic Test ($298) helps personalize your plan.

What side effects might slow my weight loss or delay starting treatment?

Nausea, constipation, and appetite loss (the goal) can occur in week 1–2 but usually fade by week 3–4. These effects rarely stop weight loss—they're signs the medication is working. Staying hydrated, eating small protein-rich meals, and going slow with dose increases minimize discomfort while keeping progress steady.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to GLP-Squared or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.